Source briefingOctober 1, 2026Human Rights

Uzbekistan: Guarantee Karakalpak Lawyer’s Safety

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.

What the source reports

Click to expand Image Dauletmurat Tazhimuratov in the defendants' cage on the last day of his trial on charges related to the July 2022 protests in Nukus, the main city in Karakalpakstan, at a court in Bukhara, Uzbekistan on January 31, 2023.  © 2023 Eurasianet (Berlin, October 1, 2026) – Uzbek officials should immediately ensure the safety and well-being of an imprisoned Karakalpak blogger and lawyer, Dauletmurat Tazhimuratov, and secure his release, Human Rights Watch said today.

Since his conviction and transfer to…

Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.

Source & verification

Primary source: Human Rights Watch News · October 1, 2026

Read the original source

FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.

Continue reading

EMA/PE/0000181364

What is established The European Medicines Agency (EMA) has granted a decision regarding a paediatric investigation plan (PIP) for vosoritide as of 8 August…

EMA/PE/0000228795

Evidence Dossier: EMA Paediatric Investigation Plan for Ambrisentan/Tadalafil What is established The European Medicines Agency (EMA) has officially adopted a paediatric investigation plan (PIP)…

EMA/PE/0000261344

Evidence Dossier: EMA Decision on Colchicine Paediatric Investigation Plan (PIP) What is established On 8 August 2025, the European Medicines Agency (EMA) granted a…